Sumatriptan Succinate Drugs, Importers, Informations, User, warnings, Reviews, Side, Effects, Symptoms, Raw Material Exporters, Details, Drug Effectiveness, Sumatriptan Succinate, Molecular Formula C14H21N3O2S.C4H6O4, Molecular Weight 413.49, CAS Registry Number 103628-48-4, fda, Information of Diseases, Drug, Details, Emergency, Interactions, api, Active Pharmaceutical Ingredients, Dosage, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Sumatriptan-Succinate Tai API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Sumatriptan Succinate Manufacturers in India Suppliers Sumatriptan Succinate Exporters Distributors Sumatriptan Succinate api active pharmaceuticals ingredients Sumatriptan Succinate manufacturers Side Effects bulk drugs raw material Sumatriptan Succinate companies Side Effects Importers Sumatriptan Succinate Sumatriptan Succinate Exporters Sumatriptan Succinate exporters FDA Sumatriptan Succinate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Sumatriptan Succinate manufacturing pharmaceutical drugs pharmaceutical intermediates Sumatriptan Succinate pharmaceutical chemicals pharmaceutical raw materials Sumatriptan Succinate active pharmaceutical ingredients Sumatriptan Succinate committee active pharmaceutical ingredients manufacturer Sumatriptan Succinate Active Pharmaceutical Ingredients manufacturer Sumatriptan Succinate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Sumatriptan Succinate, Sumatriptan Succinate manufacturer India, Sumatriptan Succinate product, Sumatriptan Succinate products, Api preparation, Certificate of Analysis API manufacturer product, Sumatriptan Succinate anti ulcer product, Certificate of Origin COA Sumatriptan Succinate COS Sumatriptan Succinate, pharmaceutical generic, pharmaceutical drug, medical, Sumatriptan Succinate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Sumatriptan Succinate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Sumatriptan Succinate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Sumatriptan Succinate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Sumatriptan Succinate ingredients, api, HIV Sumatriptan Succinate, tablets, capsules, syrup & protein Sumatriptan Succinate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Sumatriptan Succinate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Sumatriptan Succinate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Sumatriptan-Succinate

HOME >> API >> API List 3 >> Sumatriptan Succinate >> Interaction

INTERACTION
Sumatriptan Succinate CAS Number 103628-48-4

Certain medications taken with this product could result in serious, even fatal, drug interactions. Do not take MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, procarbazine, selegiline, tranylcypromine) for at least 2 weeks before or after taking this drug. Do not take other "triptan" migraine drugs (e.g., zolmitriptan, rizatriptan) or ergot-type drugs (e.g., dihydroergotamine, ergotamine, methysergide) within 24 hours of taking this medicine. Before using this medication, tell your doctor or pharmacist of all nonprescription and prescription products you may use, especially of: other drugs for prevention or treatment of headaches, "serotonin-type" medications (e.g., SSRI antidepressants such as fluvoxamine, sertraline), medication for weight control. It is recommended to avoid consumption of alcohol while taking this medication.

Dihydroergotamine, ergotamine, methysergide: increased risk of vasospastic reaction

Lithium, MAO inhibitors, selective serotonin reuptake inhibitors: weakness, hyperreflexia, incoordination

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.